Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]

Circulating levels of tumour DNA in plasma may help monitor treatment response...

Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia

Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )

Tumour specific immunotherapy in CLL

Prof Catherine Wu - Harvard Medical School, Boston, USA

Tumour specific immunotherapy in CLL ( Prof Catherine Wu - Harvard Medical School, Boston, USA )

Highlights from iwCLL 2015

Prof Stephen Mulligan - CLL Australian Research Consortium, Sydney, Australia

Highlights from iwCLL 2015 ( Prof Stephen Mulligan - CLL Australian Research Consortium, Sydney, Australia )

Cytogenetic and proteomic prognostic markers of CLL

Dr Lauren Thurgood - Flinders University, Adelaide, South Australia

Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )

Predicting progression and survival in CLL

Prof Jonathan Strefford - University of Southampton, Southampton, UK

Predicting progression and survival in CLL ( Prof Jonathan Strefford - University of Southampton, Southampton, UK )

Phase I study of duvelisib in patients with relapsed or refractory CLL

Dr Susan O’Brien – University of California, Irvine, California, USA

$Phase I study of duvelisib in patients with relapsed or refractory CLL ( Dr Susan O’Brien – University of California, Irvine, California, USA )$

The LRF CLL4 trial: long-term outcomes

Prof Daniel Catovsky - The Institute of Cancer Research, London, UK

The LRF CLL4 trial: long-term outcomes ( Prof Daniel Catovsky - The Institute of Cancer Research, London, UK )

Expert panel discussion: The best of iwCLL 2015

Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai

Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )

Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells

Dr Alexey Danilov - Oregon Health and Science University, Portland, USA

Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells ( Dr Alexey Danilov - Oregon Health and Science University, Portland, USA )

Genetic deletions in CLL

Dr Carlo Croce - The Ohio State University College of Medicine, Columbus, USA

Genetic deletions in CLL ( Dr Carlo Croce - The Ohio State University College of Medicine, Columbus, USA )

High remission rates for new CLL treatment

Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia

High remission rates for new CLL treatment ( Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia )

CLL from a patient and physician perspective

Dr Brian Koffman MD – Medical Director of the CLL Society

CLL from a patient and physician perspective ( Dr Brian Koffman MD – Medical Director of the CLL Society )

More from ecancer